Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immunocore Holdings (IMCR)
NASDAQ:IMCR
Immunocore Holdings (IMCR) Stock Price & Analysis
124 Followers
IMCR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$42.21 - $76.98
Previous Close$63.5
Volume257.30K
Average Volume (3M)482.70K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)£332.54M
Total Debt (Recent Filing)£69.30M
Price to Earnings (P/E)N/A
Beta0.61
Next Earnings
May 08, 2024EPS Estimate
-$0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding48,088,346
10 Day Avg. Volume320,921
30 Day Avg. Volume482,700
Standard Deviation0.15
R-Squared0.09
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)8.07
Price to Sales (P/S)21.24
Price to Cash Flow (P/CF)N/A
P/FCF Ratio404.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$84.27Price Target Upside39.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
Immunocore Holdings News
PremiumPress Releases
Immunocore presented two posters at CROI 2024
PremiumCompany Announcements
Immunocore Holdings Q4 and Full-Year 2023 Earnings Presentation
Ownership Overview
0.04% Insiders
17.24% Mutual Funds
43.06% Other Institutional Investors
39.66% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IMCR FAQ
What was Immunocore Holdings’s price range in the past 12 months?
Immunocore Holdings lowest stock price was $42.21 and its highest was $76.98 in the past 12 months.
What is Immunocore Holdings’s market cap?
Currently, no data Available
When is Immunocore Holdings’s upcoming earnings report date?
Immunocore Holdings’s upcoming earnings report date is May 08, 2024 which is in 19 days.
How were Immunocore Holdings’s earnings last quarter?
Immunocore Holdings released its earnings results on Feb 28, 2024. The company reported -$0.4 earnings per share for the quarter, missing the consensus estimate of -$0.248 by -$0.152.
Is Immunocore Holdings overvalued?
According to Wall Street analysts Immunocore Holdings’s price is currently Undervalued.
Does Immunocore Holdings pay dividends?
Immunocore Holdings does not currently pay dividends.
What is Immunocore Holdings’s EPS estimate?
Immunocore Holdings’s EPS estimate is -$0.36.
How many shares outstanding does Immunocore Holdings have?
Immunocore Holdings has 49,820,614 shares outstanding.
What happened to Immunocore Holdings’s price movement after its last earnings report?
Immunocore Holdings reported an EPS of -$0.4 in its last earnings report, missing expectations of -$0.248. Following the earnings report the stock price went down -1.76%.
Which hedge fund is a major shareholder of Immunocore Holdings?
Among the largest hedge funds holding Immunocore Holdings’s share is Baker Bros Advisors LP. It holds Immunocore Holdings’s shares valued at 172M.
---
Immunocore Holdings Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$84.27 (39.29% Upside)
$84.27 (39.29% Upside)
Blogger Sentiment
Bullish
IMCR Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 92.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 1.2%
Last 30 Days ▼ 1.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
19.63%
12-Months-Change
Fundamentals
Return on Equity
-15.74%
Trailing 12-Months
Asset Growth
13.96%
Trailing 12-Months
Company Description
Immunocore Holdings
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases.
---
IMCR Earnings Call
Q4 2024
0:00 / 0:00
---
IMCR Stock 12 Months Forecast
Average Price Target
$84.27
▲(39.29% Upside)
Technical Analysis
Crispr Therapeutics AG
―
Fate Therapeutics
―
Arcturus Therapeutics
―
Intellia Therapeutics
―
Best Analysts Covering IMCR
1 Year
1 Year Success Rate
7/8 ratings generated profit
1 Year Average Return
+19.48%
reiterated a buy rating 2 months ago
Copying Justin Kim's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +19.48% per trade.
---